Suzhou Ribo Life Science Co., Ltd.

Suzhou Ribo Life Science Co., Ltd. was established in 2007 by among others two distinguished Swedish/Chinese RNA-researchers in China and is today a clinical stage biotech company specialized on the development of RNA interference (RNAi) technologies and oligonucleotide therapeutics.

As the major pioneer and leader in the RNAi technology and oligonucleotide therapeutics industry in China, Suzhou Ribo Life Science Co., Ltd. has vertically integrated its cutting-edge RNAi technologies including GalNAc liver-targeting delivery technology and established the oligonucleotide drug development platform by years of efforts.

Suzhou Ribo Life Science Co., Ltd. has built up a highly capable R&D, manufacturing, and operational management team with extensive years of experiences in the pharmaceutical industry. The company is headquartered in Kunshan, Jiangsu Province, China, and has an R&D center in Beijing. 

Oligonucleotide therapeutics
disease indications

Disease indications

Specific efforts will be directed to building innovative capacities to conduct clinical trials and developing siRNA drugs for disease indications such as liver diseases, cardiovascular and metabolic diseases, as well as orphan diseases to address real unmet medical needs.

Please visit Suzhou Ribo Life Science Co., Ltd. for the current pipeline of the parent company.

Contact us for collaboration opportunities and projects ideas!

Ribocure will be expanding heavily in Sweden and looking for new talents to join, and academic associations as well as small and large enterprise partners to collaborate with, with the joint goal of developing highly differentiated and innovative oligonucleotide therapeutics to help patients in need. 

Privacy Policy (Integritetspolicy)
Your privacy is important to us. Ribocure Pharmaceuticals AB respects your privacy regarding all data we may collect from you on our website, www.ribocure.com.
 
We collect data/information to make contact and establish and maintain a relationship. We collect this information in a fair and legal way with your awareness and consent, as stipulated by GDPR (General Data Protection Regulation). We also let you know why we collect it and how it will be used.
 
The data that is stored are the fields that each submission form contains. We save the data for as long as is necessary with regard to the purposes of the processing. We always base the collection of personal data on consent.
 
You have the right to request information about what personal data we have stored about you. To do this, contact the Data Protection Officer (DPO). You also have the right to request correction or deletion of your personal data at any time.
 
Your continued use of our website will be deemed as acceptance of our privacy and personal information practices. If you have any questions about how we handle user data and personal information, please contact us.
 
Contact information to the Data Protection Officer (DPO):
 
Data Protection Officer
Ribocure Pharmaceuticals AB
Vetenskapens gränd 11
431 53 Mölndal
Sweden
 
E-mail: dpo@ribocure.com